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Abstract 
Background: Bovine leukemia virus (BLV) is a member of retroviridae family, together with human T cell leukemia 
virus types 1 and 2 (HTLV‑1 and ‑2) belonging to the genes deltaretrovirus, and infects cattle worldwide. Previous stud‑
ies have classified the env sequences of BLV provirus from different geographic locations into eight genetic groups. 
To investigate the genetic variability of BLV in South America, we performed phylogenetic analyses of whole genome 
and partial env gp51 sequences of BLV strains isolated from Peru, Paraguay and Bolivia, for which no the molecular 
characteristics of BLV have previously been published, and discovered a novel BLV genotype, genotype‑9, in Bolivia.
Results: In Peru and Paraguay, 42.3 % (139/328) and over 50 % (76/139) of samples, respectively, were BLV positive. In 
Bolivia, the BLV infection rate was up to 30 % (156/507) at the individual level. In Argentina, 325/420 samples were BLV 
positive, with a BLV prevalence of 77.4 % at the individual level and up to 90.9 % at herd level. By contrast, relatively 
few BLV positive samples were detected in Chile, with a maximum of 29.1 % BLV infection at the individual level. We 
performed phylogenetic analyses using two different approaches, maximum likelihood (ML) tree and Bayesian infer‑
ence, using 35 distinct partial env gp51 sequences from BLV strains isolated from Peru, Paraguay, and Bolivia, and 74 
known BLV strains, representing eight different BLV genotypes from various geographical locations worldwide. The 
results indicated that Peruvian and Paraguayan BLV strains were grouped into genotypes‑1, ‑2, and ‑6, while those 
from Bolivia were clustered into genotypes‑1, ‑2, and ‑6, and a new genotype, genotype‑9. Interestingly, these results 
were confirmed using ML phylogenetic analysis of whole genome sequences obtained by next generation sequenc‑
ing of 25 BLV strains, assigned to four different genotypes (genotypes‑1, ‑2, ‑6, and ‑9) from Peru, Paraguay, and Bolivia. 
Comparative analyses of complete genome sequences clearly showed some specific substitutions, in both structural 
and non‑structural BLV genes, distinguishing the novel genotype‑9 from known genotypes.
Conclusions: Our results demonstrate widespread BLV infection in South American cattle and the existence of a new 
BLV genotype‑9 in Bolivia. We conclude that at least seven BLV genotypes (genotypes‑1, ‑2, ‑4, ‑5, ‑6, ‑7, and ‑9) are 
circulating in South America.
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Background
Bovine leukemia virus (BLV) is a member of retroviridae 
family belonging to the genes deltaretrovirus, being con-
sidered a model of pathogens for human T-cell leukemia 
virus types 1 (HTLV-1) [1], and is the etiological agent of 
enzootic bovine leukosis (EBL), the most common neo-
plastic disease of cattle [2, 3]. Some cattle infected with 
BLV suffer from lymphomas and/or B-lymphocyte pro-
liferation (persistent lymphocytosis), but the majority of 
BLV-infected cattle are healthy carriers of the virus [2, 3].
The complete genome of BLV consists of 8714 nucleo-
tides, including the structural and enzymatic gag, pro, pol, 
and env essential genes and two identical long terminal 
repeats (LTRs). The BLV gag gene is translated as the pre-
cursor, Pr70 Gag, and processed into three mature proteins: 
the matrix protein, p15 (MA), the most abundant capsid 
protein, p24 (CA), and the nucleocapsid protein, p12 (NC) 
[4, 5]. The BLV pro and pol genes encode proteases (Pro) 
p14 and p80, harboring reverse transcriptase (RT) and 
integrase (IN) activities, respectively [3, 4]. The env gene 
encodes a mature surface glycoprotein (gp51) and a trans-
membrane protein (gp30) [4], and is involved in viral infec-
tivity [6–8]. In addition, the BLV genome contains a pX 
region, located between the env sequence and the 3′ LTR 
[2, 3]. At least four proteins, including the regulatory pro-
teins Tax and Rex, and the accessory proteins R3 and G4, 
are encoded by this genomic region. The Tax protein has 
been extensively studied and is believed to play a critical 
role in BLV induced leukemogenesis [9]. Rex is responsible 
for nuclear export of viral RNA and promotes cytoplas-
mic accumulation and translation of viral messenger RNA 
(mRNA) in BLV-infected cells [10]. The R3 and G4 proteins 
contribute to the maintenance of high viral load [11, 12] and 
the G4 protein is particularly relevant to leukemogenesis, 
since it can immortalize primary embryonic fibroblasts [13]. 
The R3 protein contributes to the maintenance of infectivity 
[12], and is located in the nucleus and cellular membranes 
[13]. In addition to the above, BLV RNA polymerase III 
(pol III)-encoded viral microRNAs are strongly expressed 
in preleukemic and malignant cells, in which structural and 
regulatory gene expression is repressed, suggesting a possi-
ble key role in tumor onset and progression [14, 15].
The Env gp51 glycoprotein plays an essential role in the 
viral life cycle [7, 8]. gp51 is required for cell entry and 
the target of neutralizing antibodies [8, 16]. The N-ter-
minal half of BLV gp51 contains three conformational 
epitopes, F, G and H [17], and plays an important role 
in viral infectivity and syncytium formation [7, 18, 19], 
while the C-terminal half of BLV gp51 contains the lin-
ear epitopes A, B, D, and E [16, 17]. Therefore, the gp51 
region has been widely used for BLV genotyping studies 
and recent phylogenetic studies of this region from viral 
strains isolated worldwide demonstrate that BLV can be 
classified into at least eight genotypes [20–33].
Cattle were introduced to the American continent by 
the Spanish conquerors from 1493. Within a few years, 
these cattle had spread all over South America and their 
population size had increased to several million [34]. 
More than 300  years, Creole cattle were the only cat-
tle bred in America, and during the end of 19th and 
the beginning of the 20th centuries, animals from Brit-
ish breeds (Shorthorn, Hereford, Angus, and Holstein) 
and indicus breed (Nelore, Brahman, and Gir) were 
introduced in temperate/cold and subtropical/tropical 
regions, respectively, in order to improve beef and dairy 
production through crossbreeding with local populations 
or directly by replacement. BLV infects cattle worldwide, 
imposing a severe economic impact on the dairy cattle 
industry, and EBL has been recognized in South America 
(Brazil) since 1943 [35]. World Organization for Animal 
Health data (OIE 1999 and 2009) has confirmed the pres-
ence of BLV in most parts of South America. In Brazil, 
infection rates between 17.1 and 60.8  % were detected, 
with individual prevalence rates varying considerably 
among states, and recent data indicate a sharp increase in 
the prevalence of BLV [20, 23, 35–38]. Early phylogenetic 
analysis of the BLV env gene demonstrated that Brazilian 
BLV isolates were clustered into genotypes-1, -2, -5, -6, 
and -7 [20, 23]. In Columbia, BLV prevalence levels up 
to 83.3  % have been reported, with average prevalence 
differing significantly between cattle breeds and accord-
ing to the viral detection method used [39, 40]. Previous 
studies have indicated the presence of BLV in Argentina 
[26, 31, 41, 42], with individual and herd prevalence lev-
els of 32.8 and 84  %, respectively [43]. The presence of 
BLV genotypes-1, -2, -4, and -6 were confirmed in Argen-
tina [26, 31, 32]. BLV infection has also been reported in 
Peru, Chile, and Uruguay [24, 33, 44]. Restriction frag-
ment length polymorphism (RFLP) analysis of Chilean 
BLV strains demonstrated the presence of genotypes-1 
and -4 [24]; however, a study of cattle in Uruguay and 
Chile by Moratorio et  al. [33], aligning partial env gp51 
sequences with data available from other South Ameri-
can BLV strains, found that Chilean BLV strains were 
assigned into genotypes-4 and -7, but not -1, while Uru-
guayan BLV strains were of genotype-1. Thus, it appears 
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that at least six genotypes of BLV strains are circulating 
in South America. However, there are currently no stud-
ies of the molecular characteristics of BLV in Bolivia, Par-
aguay, or Peru (OIE 2009).
Here, we investigated the distribution of and molecu-
larly characterized BLV strains in Peru, Paraguay, Bolivia, 
Argentina, and Chile, together with other South Amer-
ican BLV strains as follows: (1) first, the spread of BLV 
infection was investigated by amplification of BLV LTRs 
by nested polymerase chain reaction (PCR) from blood 
samples obtained from a total of 2204 cattle in Peru, 
Paraguay, Bolivia, Argentina, and Chile; (2) second, the 
genetic variability of BLV strains circulating in Peru, 
Paraguay, and Bolivia was examined by DNA sequenc-
ing and 35 distinct strains collected from these countries 
were classified by genotype using phylogenetic analyses 
based on partial env (gp51) sequences, comparing these 
strains and isolates from other geographical locations 
worldwide; (3) third, whole genome sequences of 25 BLV 
strains, assigned to four different genotypes, from Peru, 
Paraguay and Bolivia were obtained by next generation 
sequencing (NGS) and compared with eight full-length 
BLV genome sequences, generated by Sanger sequencing, 
available in the NCBI database.
Collectively, our comprehensive studies provide strong 
evidence for the existence of a novel BLV genotype, 
which we designate genotype-9, in Bolivia.
Results
Investigation of the spread of BLV infection in South 
America
To investigate the spread of BLV infection in South 
America, a total of 2204 blood samples were collected 
from cattle in different regions of five South American 
countries, including Peru, Paraguay, Bolivia, Argentina, 
and Chile, as shown in Fig. 1. The samples were screened 
for BLV infection by nested PCR to amplify BLV LTRs 
(Table 1; Fig. 1). In Peru, samples from 139 cattle out of 
328 (42.3  %) were positive for the BLV provirus, with 
prevalence rates ranging from 0 to 58.6  % at the farm 
level. In Paraguay, 76 cattle samples out of 139 (54.5 %) 
were BLV positive and infected cattle breeds were Hol-
stein, Brown Swiss, or Holstein  ×  Brown Swiss. All 
breeds showed a high prevalence of BLV infection in Par-
aguay, with a range of 28.6–71.4 % in the Holstein breed 
and 36.4  % in Brown Swiss. Of 507 samples collected 
from eight farms in different parts of Bolivia, 156 (30.7 %) 
were positive for BLV provirus. Infected cattle breeds in 
Bolivia were Holstein, Gir and Yacumeño, but not Brown 
Swiss, Brahman and Montana. Interestingly, BLV infec-
tion levels differed from farm to farm, and from breed to 
breed. For example, Holstein cattle showed the highest 
BLV prevalence, with up to 100 % at the individual level, 
while Yacumeño showed moderate levels of BLV infec-
tion ranging from 4.5 to 24.3 %. Compared to the above-
mentioned countries, samples collected from Argentina 
(n  =  420) demonstrated extremely high levels of BLV 
prevalence (77.4 %), with up to 90.9 % at the herd level. 
In Chile, 810 samples were collected from multiple cat-
tle breeds at 19 farms over a relatively wide geographi-
cal area (Table 1). Of the samples screened, 236 (29.1 % 
prevalence) were BLV provirus positive. It is difficult to 
compare BLV prevalence levels between breeds in Chile, 
as a wide range of breeds were BLV positive; however, 
remarkable differences were observed between farms, 
breeds, and locations, indicating variability of BLV infec-
tion in this country. Our study result is in agreement 
with previous study [45, 46] that on average dairy cattle 
breeds, such as Holstein and Brown Swiss, has higher 
level of BLV infection than that of beef cattle, namely 
Yacumeño and Nelore. However, there is no statistically 
significant correlation of BLV prevalence among Breeds, 
because individually breeds are different from farm to 
farm and also from country to county.
Identification of a novel BLV genotype, genotype‑9, 
by phylogenetic analysis of partial env gp51 sequences
Recent phylogenetic studies on the env gene of BLV 
strains isolated worldwide demonstrate that these viruses 
can be classified into eight genotypes [20–33]. How-
ever, no studies of the molecular characteristics of BLV 
in Bolivia, Paraguay, and Peru have previously been 
published. Therefore, to gain insight into the degree of 
genetic variability of BLV strains in South America, par-
tial sequences of env gp51 from 131 field strains, repre-
senting 30 % of BLV positive samples collected from each 
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Fig. 1 Map of South America showing the number of cattle (head) 
sampled from countries included in the study. The five countries and 
cities/municipalities where sampling was performed are indicated in 
the figure. n indicates the total number of samples in each country 
and BLV(+) % indicates the BLV prevalence rate
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Table 1 Summary of BLV detection by nested PCR for five South American countries
Country City/municipality Farm Breed Positive % (+/All)a
Peru Lima A Holstein 58.6 (61/104)
Pucallpa B Brahman × Nelore 40.0 (78/195)
Huancayo C Holstein 0.0 (0/29)
Paraguay Asuncion A Holstein 71.4 (25/35)
B Holstein 60.0 (18/30)
C Holstein 61.3 (19/31)
D Holstein 33.3 (1/3)
E Holstein 28.6 (8/28)
Brown Swiss 36.4 (4/11)
Holstein × Brown Swiss 100.0 (1/1)
Bolivia Yapacani A Yacumeño 27.7 (10/36)
B Yacumeño 19.0 (4/21)
C Yacumeño 4.5 (1/22)
Brown Swiss 0.0 (0/1)
D Yacumeño 24.3 (7/29)
Montero E Holstein 38.0 (19/50)
F Gir 18.5 (20/108)
Nelore 20.0 (21/105)
Portachuelo G Holstein 64.2 (70/109)
Santacruz H Brahman 0.0 (0/3)
Gir 0.0 (0/2)
Holstein 100.0 (1/1)
Montana 0.0 (0/2)
Nelore 9.0 (1/11)
Brahman × Nelore 28.6 (2/7)
Argentina Buenos Aires D Holstein 90.9 (60/66)
E Holstein 79.4 (152/194)
F Holstein 70.6 (113/160)
Chile Valdivia A Overo Colorado 12.0 (3/25)
B Chilean Wagyu 50.0 (1/2)
Simmental 0.0 (0/1)
Jersey 0.0 (0/1)
Overo Colorado 0.0 (0/5)
Overo Negro 0.0 (0/2)
Red Angus 0.0 (0/2)
C Overo Colorado 100.0 (30/30)
Mafil D Holstein 0.0 (0/4)
Overo Colorado 3.1 (1/32)
E Holstein 30.0 (9/30)
F Hereford × Overo Colorado 30.0 (6/20)
San Jose de la Mariquina G Hereford × Jersey 91.7 (66/72)
H Holstein 50.0 (10/20)
Panguipulli I Overo Colorado 7.7 (6/13)
Overo Negro 30.0 (10/33)
J Overo Colorado 16.6 (1/6)
Overo Negro 38.5 (20/52)
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country, were amplified. After direct sequencing of these 
amplicons, because of strains from the same farm having 
100 % identity to each other, 475 bp nucleotide sequences 
of 35 distinct strains among 131, corresponding to nucle-
otide positions 5090–5564 of the full-length BLV genome 
(BLV cell line FLK-BLV strain pBLV913, accession num-
ber EF600696) [47], were aligned with 74 corresponding 
sequences from known BLV strains, representing eight 
different BLV genotypes from additional South Ameri-
can countries (Argentina, Brazil, Chile, and Uruguay) and 
other parts of the world [27–29, 32]. Phylogenetic trees 
were then constructed using Maximum likelihood (ML; 
Fig.  2) and Bayesian Inference (BI; Fig.  3) approaches. 
The ML and BI trees showed congruent topologies, sup-
ported by moderate to high bootstrap values and high 
posterior probabilities. As shown in Figs. 2 and 3, in con-
trast to previous studies where only eight BLV strains 
were detected, both methods of phylogenetic tree con-
struction identified nine sequence clusters, designated 
genotypes 1-9. All of the BLV strains we collected from 
Peru were assigned to genotypes-1, -2, and -6. Likewise, 
the majority of Paraguayan BLV strains clustered into 
genotypes-1 and -6, with a small number in genotype-2, 
together with Argentine BLV strains. Interestingly, the 
BLV strains collected from Bolivia clustered not only into 
genotypes-1, -2, and -6, together with our Peruvian and 
Paraguayan strains, but also into a unique clade, which 
was distinct from the eight previously known BLV geno-
types. This result demonstrates that some of our Boliv-
ian BLV strains did not cluster with any others and were 
highly divergent from the eight known genotypes. This 
novel genotype displayed a high bootstrap support-
ing value (92  %) in the ML tree (Fig. 2) and a posterior 
probability of 100 % using the BI approach (Fig. 3), indi-
cating the presence of new genotype, genotype-9. Fur-
thermore, the genotyping result of reference sequences 
from Argentine, Brazil, Chile and Uruguay in this study 
is in agreement with previous studies [20, 23, 24, 26, 31, 
32]. Argentine BLV strains were mainly assigned into 
genotypes-1 and -2, with relatively few samples grouped 
into genotypes-4 and -6. Reference sequences of Bra-
zilian BLV strains demonstrated a wider variety of BLV 
genotypes, consisting of genotypes-1, -2, -5, -6, and -7. 
Known Chilean BLV strains were limited to genotypes-4 
and -7. In addition, strains from Uruguay were assigned 
to genotype-1 only. Thus, our results demonstrate that 
BLV strains assigned to at least seven genotypes (geno-
types-1, -2, -4, -5, -6, and -7, plus the novel genotype-9) 
are circulating in South America. 
Whole genome sequencing and sequence comparison 
of strains with genotypes‑1, ‑2, and ‑6, and a novel 
genotype‑9
To compare the divergence of the BLV whole genome, 
overlapping genomic fragments covering the complete 
BLV genomic sequence were amplified from strains 
grouped into the novel genotype-9 and those in other 
genotypes, namely genotype-1, -2 and -6, as deter-
mined by dual phylogenetic analyses of partial env gp51 
sequences. Twenty-five samples, including one from 
Peru, seven from Paraguay, and 17 from Bolivia, were 
amplified by PCR (Additional file  1: Figure S1) and the 
amplicons were pooled to construct a DNA library 
for multiplex sequencing on the MiSeq system (Illu-
mina). Short-read sequences were assembled using 
three BLV reference sequences (Accession numbers; 
Table 1 continued
Country City/municipality Farm Breed Positive % (+/All)a
Rio Bueno K Holstein 12.1 (4/33)
L Holstein 39.3 (11/28)
Lago Ranco M Black Angus 0.0 (0/17)
Red Angus 0.0 (0/7)
N Overo Colorado 10.5 (2/19)
La Union O Overo Negro 5.0 (1/20)
Futrono P Black Angus 41.7 (15/36)
Red Angus 19.7 (12/61)
Q Chilean Wagyu 2.5 (2/79)
Hereford 0.0 (0/1)
Red Angus 12.5 (2/16)
R Hereford × Angus 14.7 (14/95)
Llefen S Hereford 20.8 (10/48)
a (+/All) indicates the ratio of the number of BLV positive samples to that of all samples
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EF600696, FJ914764, and AF033818) and the average 
depth of genome coverage was between 143 and 1558 
(Additional file  2: Table S1). Moreover, results of analy-
ses of whole genome sequences were 100 % concordant 
with those of partial env sequences produced by Sanger 
sequencing. Comparative analyses indicated that whole 
genome sequences obtained from the 25 samples showed 
98.29–100  % homology with each other, while they 
were 95.63–99.42  % homologous to the FLK-BLV strain 
pBLV913 sequence.
We next calculated the average substitution rate of 
paired sequences for each gene between the 25 novel 
complete BLV provirus genomes and those of eight pre-
viously reported BLV whole genomes. The numbers of 
nucleotide and amino acid substitutions per site were 
estimated using the Jukes and Cantor, and p-distance 
models, respectively. Table 2 indicates the degree of vari-
ation in each of the structural genes for a total of 33 BLV 
strains, including gag (p15, p12, and p24), pro, pol, and 
env (gp30 and gp51), non-structural genes, including the 
tax, rex, R3, and G4, and LTRs. The average nucleotide 
substitution rate for the whole BLV genome was 0.023 
per site. Comparisons between each gene revealed that 
G4, rex, and the LTR genes had the lowest average nucle-
otide substitution rates. By contrast, the genes R3, p24, 
and gp30 revealed the highest average rate of nucleotide 
substitution. Comparison of amino acid substitution 
rates between BLV proteins revealed that tax and R3 
were the most polymorphic, whereas p24 was signifi-
cantly conserved.
Confirmation of the existence of a novel BLV genotype, 
genotype‑9, by phylogenetic analysis of whole genome 
sequences
Twenty-five novel and eight previously reported BLV 
whole genome sequences, which were assigned to geno-
types-1, -2 and -4, were used to construct a ML phylo-
genetic tree (Fig. 4). Since the whole genome sequences 
of genotypes-3, -5, -6 and -8 are not available, we 
sequenced, for the first time, the whole genome sequence 
of genotypes-6 and included in phylogenetic analysis. The 
tree clearly demonstrates stratification of BLV genotypes, 
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Fig. 2 Maximum likelihood phylogenetic tree of BLV env partial 
sequences from different geographical locations worldwide. A maxi‑
mum likelihood phylogenetic tree was constructed from 35 distinct 
475 bp BLV env sequences (submitted to the GenBank nucleotide 
sequence database and assigned accession numbers LC075543–
LC075577) and with 74 sequences from known BLV strains, repre‑
senting eight different BLV genotypes from other South American 
countries, including Argentina, Brazil, Chile, and Uruguay, and other 
parts of the world. These 74 nucleotide sequences were obtained from 
the GenBank nucleotide sequence database. The South American BLV 
strains in this study are indicated by sample ID and location of collec‑
tion. Other isolates are shown in the tree by accession number and 
country of origin. South American BLV strains in this study are marked 
according to the country of origin as follows: Peru (filled triangle), Para‑
guay (filled circle), and Bolivia (filled diamond). Genotypes are indicated 
by numbers to the right of the figure. Genotypes‑1, ‑2, ‑3, ‑4, ‑5, ‑6, ‑7, 
‑8 and ‑9 are shown in pastel blue, violet, sea green, blue, pink, twilight 
violet, avocado green, brown and orange, respectively. The bar at the 
bottom of the figure denotes distance
◂
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Fig. 3 Bayesian phylogenetic tree of BLV env partial sequences from different geographical locations worldwide. A Bayesian phylogenetic tree was 
constructed from 35 distinct 475 bp BLV env sequences generated in this study, together with 74 sequences from known BLV strains, representing 
eight different BLV genotypes from other South American countries, including Argentina, Brazil, Chile and Uruguay, and other parts of the world. 
Strains in the tree are indicated by accession number and country of origin. South American BLV strains from this study are marked by country of 
origin as follows: Peru (filled triangle), Paraguay (filled circle), and Bolivia (filled diamond). Genotypes are indicated by numbers around the circumfer‑
ence of the figure. Genotypes‑1, ‑2, ‑3, ‑4, ‑5, ‑6, ‑7, ‑8, and ‑9 are shown in pastel blue, violet, sea green, blue, pink, twilight violet, avocado green, brown 
and orange, respectively. Numbers at nodes indicate posterior probabilities. The bar at the bottom of the figure denotes distance
Table 2 Nucleotide and  amino acid substitution rate for  25 novel BLV complete provirus and  eight known BLV whole 
genome
a Average nucleotide substitution per site calculated using the Jukes-Canter model
b Average amino acid substitution per site calculated using the p-distance model
LTR p15 p24 p12 pro pol gp51 gp30 tax rex R3 G4 All
Nucleotidea 0.013 0.023 0.030 0.022 0.025 0.023 0.023 0.027 0.023 0.016 0.027 0.013 0.023
Amino‑acidb – 0.020 0.006 0.012 0.021 0.014 0.018 0.018 0.053 0.030 0.057 0.028 –
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including genotypes-1, -2, -4, and -6, and the novel geno-
type-9, into separate clades (Bootstrap values 100  % for 
every clade). Thus, this analysis provides evidence for 
the existence of a novel genotype-9, since the results 
were identical to those obtained using partial env gp51 
sequences. However, in this tree based on BLV whole 
genome sequences, genotype-9 sequences from Porta-
chuelo and Montero were grouped in separate branches. 
This result indicates at least two different strains within 
the novel genotype-9 in Bolivia.
Variations in structural and non‑structural genes in 16 
distinct novel BLV whole genome sequences from Peru, 
Paraguay, and Bolivia
To compare the new BLV genotype-9 with previously 
reported South American genotypes-1, -2, and -6, whole 
nucleotide or predicted amino acid sequences, includ-
ing gag (p15, p12, and p24), pro, pol, env (gp30 and gp51), 
non-structural genes, including tax, rex, R3, G4, LTRs 
and miRNAs of 16 distinct strains, selected from 25 
unique strains were aligned, using the FLK-BLV strain 
pBLV913 as a reference sequence (Figs. 5, 6, 7, 8, 9, 10).
BLV transcription is initiated at the U3-R junction of 
the 5′-LTR by the Tax protein. Transactivation requires 
the presence of three 21  bp enhancer elements (Tax-
responsive elements, TxRE) located in the U3 region of 
the 5′-LTR. Each TxRE contains a cyclic AMP-respon-
sive element (CRE) and an E-box sequence, which over-
laps the CRE motif. The U3 region also contains a PU.1/
Spi-B binding site and a glucocorticoid responsive ele-
ment (GRE). In addition, BLV expression is regulated 
by 5′-LTR sequences downstream of the transcription 
initiation site (DAS) at the 3′end of the R region and an 
interferon regulatory factor (IRF) binding site in the U5 
region. Comparison of the 16 LTR sequences of four 
South American genotypes, genotypes-1, -2, -6 and -9, 
with that of FLK-BLV strain pBLV913 revealed that these 
entire regions, including the CRE motifs, E Boxes, CAT 
Boxes, polyadenylation sites (PAS), and IRF binding sites, 
were well conserved overall (Fig.  5). Interestingly, three 
nucleotide changes were observed downstream of the 
DAS, at residues 374, 399, and 400 in sequences of geno-
type-9 strains and strains of other genotypes. There are 
also some nucleotide changes outside of the functional 
motifs (Fig. 5).
Gag is a polyprotein precursor made up of p15 MA, 
p24 CA, and p12 NC proteins (Fig.  6a). All of these 
polyprotein regions were highly conserved among the 
aligned sequences. For the p15 MA protein, sequences of 
three strains assigned to BLV genotype-1 were identical 
to that of pBLV913, whereas BLV strains clustered into 
genotypes-2, -6, and -9 had amino acid substitutions at 
residues 48, 61, 63, 69, 88 and 90 (Fig. 6a). The p24 CA 
protein region was also well conserved overall, with sub-
stitutions detected at residues 318 (V318 M/I/T), and 323 
(V323I) (Fig. 6a). The p12 NC protein is constituted of a 
region rich in basic amino acid residues and zinc bind-
ing domains involved in RNA packaging, both of which 
?Portachuelo?2? 57Portachuelo?? 46Portachuelo?? 71Portachuelo?? 87Portachuelo??Portachuelo?14? 25Portachuelo?? 93Portachuelo?? 84Portachuelo?? 108Portachuelo?? 20Portachuelo?? 28Portachuelo??Montero-254??Montero-235?Lima-40?Asuncion-43
 Arg38?Asuncion-1 ?Asuncion-62
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G-6?????? ?????????? ????????? ??? ???
?????
????? Arg41 Japanese strain FLK-BLV subclone pBLV913 LS1 LS2 LS3 US strain?Montero-214?Asuncion-5?Asuncion-41 ?Asuncion-89?Asuncion-91??Montero-241?Montero-230
Fig. 4 Maximum likelihood phylogenetic tree constructed using 
complete BLV genomic sequences. A maximum likelihood phyloge‑
netic tree was constructed from complete genomic sequences of BLV 
strains from a total of 25 samples (submitted to GenBank nucleotide 
sequence database and assigned accession numbers LC080664, 
LC080670, LC080669, LC080671, LC080673, LC080665, LC080667, 
LC080674, LC080672, LC080675, LC080666, LC080668, LC080663, 
LC080659, LC080661, LC080662, LC080660, LC080654, LC080655, 
LC080651, LC080652, LC080653, LC080656, LC080657, LC080658) 
including one sample from Peru, seven from Paraguay and 17 from 
Bolivia, together with eight reference sequences obtained from the 
GenBank nucleotide sequence database (whole genomes of FLK‑BLV 
pBLV913, LS1, LS2, LS3, Arg41, Arg38, Japan, and USA with acces‑
sion numbers EF600696, HE967301, HE967302, HE967303, FJ914764, 
AF257515, K02120, and AF033818, respectively). Gaps/missing data 
were treated as partial deletions and, finally, 8374 of 8728 sites were 
used for the calculation. One thousand replications were performed 
for calculation of bootstrap values (indicated on the tree). Strains from 
this study are indicated in the tree by the sample ID together with the 
location of collection. Reference sequences in the tree are indicated 
by strain name. Genotypes are indicated by numbers to the right 
of the figure. South American BLV strains in this study are marked 
according to country of isolation as follows: Peru (filled triangle), Para‑
guay (filled circle), and Bolivia (filled diamond). Genotypes‑1, ‑2, ‑4, ‑6, 
and ‑9 are shown in pastel blue, violet, blue, twilight violet and orange, 
respectively. The bar at the bottom of the figure denotes distance
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Fig. 5 Alignment of BLV 5′LTR nucleotide sequences. Alignment of 5′LTR nucleotide sequences from a total of 16 South American BLV strains, 
including one, seven, and eight samples from Peru, Paraguay, and Bolivia, respectively, together with that of the FLK‑BLV strain pBLV913. Strains from 
South America are shown by location of sample collection and sample ID. Identity with the FLK‑BLV strain is indicated by dots. The U3, R, and U5 
regions are indicated above the alignment. The three TxRE enhancer regions are shown in green, cyclic AMP‑responsive element (CRE) sequences 
are underlined, and E‑Box sequences are shown in italics. Binding sites for PU.1/Spi‑B are shown in bold. The glucocorticoid responsive element 
(GRE) binding site is shown in bold and underlined. Nuclear factor κB (NF‑κB) binding sites are shown double underlined. The CAT box and GATAA box 
promoters (PROMT) sequences are indicated in yellow and in bold italics, respectively. The polyadenylation site (PAS) is shown in grey and the CAP 
site is shown in blue. The downstream activator sequence (DAS) and the interferon regulatory factor (IRF) binding sites are shown in pink and light 
pink, respectively
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are very well conserved. A study by Wang et  al. con-
cluded that substitutions affecting either the basic amino 
acid residues or the zinc finger domains might lead to a 
reduction in RNA packaging [48]. In our study, all basic 
residues and Zn finger domains were conserved in the 
BLV strains analyzed (Fig.  6a), but a substitution from 
Proline to Serine at amino acid residue 340 (P340S) was 
detected in the p12 NC protein region of South Ameri-
can genotype-1 strains. This substitution has previously 
been reported in genotype-1 BLV strains LS1, LS2, and 
SL3 [49]. In addition, another substitution at residue 365 
(A365T) was detected in strains of genotypes-2, -6, and 
-9. However, the functional consequences of these substi-
tutions are unknown.
The BLV Pro protein is an aspartic protease with a 
function in gag processing and thus virion maturation 
[49]. As shown in Fig. 6b, although substitutions at resi-
dues 13, 81, 91, 134, 148 and 149 were detected among 
the Pro protein sequences of South American strains, 
this region was generally well conserved and no new gen-
otype-specific substitutions were detected.
The deduced BLV RT and IN amino acid sequences 
encoded by the pol gene of all of 16 South American BLV 
strains were also highly conserved (Fig. 7). The polymer-
ase (Pol) amino acid sequences of the 16 samples were 
similar to the reference sequence; however, interesting 
and important findings included substitutions of glu-
tamic acid to aspartic acid (E166D) and aspartic acid to 
glycine (D447G) in the RT region, and from histidine to 
tyrosine (H644Y) and alanine to threonine (A826T) in 
the IN region, observed only in all sequences of strains 
assigned to the new BLV genotype-9 (Fig.  7). In addi-
tion, an asparagine to serine substitution (A792S) was 
detected only in the IN protein sequence of all 12 sam-
ples collected from Portachuelo, which were grouped 
into genotype-9, but this substitution was not detected 
in other genotype-9 strains, indicating that particu-
lar amino acid changes could be limited to certain geo-
graphic regions (Fig. 7). In addition, nine substitutions at 
residues 209, 231, 268, 350, 399, 437, 695, 814, and 839 
were found in the Pol protein region of three sequences 
from Bolivian strains clustered into genotype-6.
The sequences encoding the Env leader peptide and 
gp30 protein were highly conserved among all of our 16 
South American BLV strains, as were those of gp51 pro-
teins (Fig. 8). Comparisons of conformational (F, G, and 
H) and linear (A, B, D, and E) epitopes demonstrated that 
A, B, E, F, and H were conserved, while the G-epitope 
at residues 48, 74 and 82, and D-epitope at residues 254 
and 267 showed divergence (Fig. 8). The K74R substitu-
tion has previously been described in env gp51 partial 
sequence deposited in the GenBank database [32]. The 
S82F substitution was present in sequences from strains 
grouped to genotypes-2, -6, and -9. Interestingly, the 
S82L substitution was detected only in all 12 sequences 
of Portachuelo-derived strains grouped in genotype-9. 
Of the neutralizing domains, the first and third were 
conserved, while the second demonstrated some gen-
otype-specific substitutions (Fig.  8). Genotype-1 sam-
ples collected from Paraguay showed substitutions of 
aspartic acid to asparagine at residue 134 (D134N) and 
of phenylalanine to serine at residue 146 (F146S), which 
have previously been observed in some env gp51 par-
tial sequences isolated from Uruguay and Brazil [33]. In 
addition, BLV strains assigned into genotypes-2 and -6 
also showed specific substitutions, N141D and I144T, 
respectively, in the second neutralizing domain. Inter-
estingly, one significant substitution was observed at 
position 133 of the gp51 protein, with alanine (A) sub-
stituted for valine (V) in all BLV genotype-9 strains, in 
agreement with results obtained by direct sequencing of 
the partial gp51 env region. Furthermore,both gp51 par-
tial sequences and full genome sequences showed the 
conservation of all of the eight N-linked glycosylation 
sites. In the gp30 protein, the fusion peptide and GD 21 
were highly conserved, while cytoplasmic domain of the 
transmembrane protein showed divergence with some 
substitutions, including Q470E, L479F, T480A, H500R, 
and V504T, commonly detected in South American BLV 
strains of various genotypes (Fig. 8).
The functional domains of the BLV Tax protein, which 
regulates BLV expression, include a putative zinc finger 
motif (residues 30–53) [2, 3], a leucine-rich activation 
domain (residues 157–197) [50], two phosphorylation 
sites (residues 106 and 293) [51], and a multi functional 
domain (residues 240–265) [2, 52–57]. These domains 
were assigned in the four South American genotypes, -1, 
-2, -6, and -9, and pBLV943, and compared between the 
16 distinct strains. In the deduced amino acid alignments 
of the three functional domains of Tax, substitutions at 
residue 40 (Q40R) in the zinc finger domain, residue 164 
(S164P), residue 169 (L169I) and residue 183 (R183  K) 
(See figure on next page.) 
Fig. 6 Alignment of amino acid sequences of BLV Gag and Protease (Pro) proteins. Alignment of amino acid residues corresponding to Gag poly‑
protein (a) and Pro protein (b) from a total of 16 South American BLV strains including one sample from Peru, seven from Paraguay, and eight from 
Bolivia, together with that of FLK‑BLV strain pBLV913. Arrows designate the putative Matrix (p15MA), Capsid (p24CA) and Nucleocapsid (p12NC) 
protein sequences. Zinc finger domains are shown in purple. NC residues in boldface indicate basic residues. Identity with the FLK‑BLV strain is 
indicated by dots
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Fig. 7 Alignment of amino acid sequences of BLV polymerase (Pol) proteins. Alignment of amino acid residues corresponding to Pol proteins of a 
total of 16 South American BLV Strains, including one sample from Peru, seven from Paraguay and eight from Bolivia, together with that of the FLK‑
BLV strain pBLV913. Arrows designate the putative reverse transcriptase (RT) and integrase (IN) regions. Identity with the FLK‑BLV strain is indicated 
by dots
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Fig. 8 Alignment of amino acid sequences of BLV Envelope (Env) proteins. Alignment of amino acid residues corresponding to Env proteins from a 
total of 16 South American BLV strains, including one sample from Peru, seven from Paraguay and eight from Bolivia, together with that of the FLK‑
BLV strain pBLV913. Arrows designate the putative gp51 (SU) and gp30 (TM) proteins. The leader peptide is double underlined. The conformational 
epitopes, F, G and H are indicated in bold and underlined. Linear epitopes, A, B, D and E are shown in italics and underlined. Amino acids involved in 
neutralization domains are shown in bold. The CD4+ T and CD8+ T epitopes are shown in pink and purple, respectively. GD21 is shown in blue. The 
cytoplasmic domain is indicated in green. Identity with the FLK‑BLV strain is indicated by dots. The eight N‑glycosylation sites are shown in orange 
box
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in the leucine-rich activation domain, and residue 257 
(C257 N) in the multi functional domain were detected 
in South American BLV strains (Fig. 9a). By contrast, the 
two phosphorylation sites were conserved in all South 
American BLV strains included in this study. The most 
important findings in the alignment of the Tax protein 
were substitutions at residue 108 (F108L), detected only 
in sequences of all of the new South American geno-
type-9 BLV strains, and a substitution at residue 100 
(P100S), observed only in samples collected from Porta-
chuelo, indicating genotype-9 and/or Portachuelo region 
specific mutations in Tax.
Another BLV regulatory protein, Rex, is associated 
with nuclear pores and harbors a nuclear localization 
signal (NLS) and a nuclear export signal (NES) required 
for RNA-binding and nuclear localization (Fig.  9b). 
Alignment of deduced amino acid sequences from the 
16 South American BLV strains showed that the NLS 
domain was well conserved, while one substitution 
(A80S) was detected in the NES of the majority of sam-
ples. In addition, other mutations, including M39T, T72P, 
and L146S, were commonly detected in BLV strains 
with genotypes-2, -6, and -9, and were also present in 
sequences deposited in the GenBank database. Five sub-
stitutions at residues 12, 40, 53, 58, and 70 were detected 
only in BLV strains of genotype-6. Of interest, one sub-
stitution at residue 113 (A113E) of the Rex protein was 
observed only in all genotype-9 strain sequences.
The amino acid sequence of the accessory protein, G4, 
includes an amino terminal stretch of hydrophobic resi-
dues (amino acids 1–24) followed by a potential proteo-
lytic cleavage site, a myb-like motif (MYB; amino acids 
39–44) and an arginine-rich region (ARR; amino acids 
58–72) located in the middle of the protein [58] (Fig. 9d). 
The MYB and ARR of G4 were well conserved; however, 
a substitution from phenylalanine to serine at residue 
22 was detected in one of the two cleavage sites in three 
South American BLV strains of genotypes-2 and -6. The 
functional effect of this F22S substitution is unknown. 
Other point mutations at residues 7, 25, 26, 27, 35, 45, 55, 
and 71 were found in some South American BLV strains.
By contrast, as shown in Fig. 9c, the alignment of the 
deduced amino acid sequences of another accessory 
protein, R3, demonstrated that a substitution at residue 
26 (N26H) was detected only in the sequences of all geno-
type-9 BLV strains. In addition, four substitutions, Q12E, 
K27E, H35Y and L40S, were observed only in three South 
American BLV strains clustered into genotype-6, indicat-
ing genotype-specific mutations in the R3 protein.
BLV-encoded micro RNAs (miRNAs) might possi-
bly play potential roles in the regulation of gene expres-
sion and in tumor development [14, 15]. In this study, 
we also obtained sequences of ten unique BLV miRNAs 
derived from five predicted miRNA precursor hair-
pins, BLV-premiR-B1 to -B5 (Fig.  10), corresponding 
to those included in previous studies [14, 15]. All of the 
ten miRNA sequences were well conserved, with BLV-
miRNA-B2-5p, BLV-miRNA-B3-5p, and BLV-miRNA-
B3-3p conserved in all four South American BLV 
genotypes included in the analysis. In addition, the seed 
sequences of the predominant arms of seven of the ten 
miRNAs were identical across all examined BLV strains. 
However, all genotype-9 BLV strains had an A to G nucle-
otide change in the seed sequence of BLV-miRNA-B5-3p. 
In addition, nucleotide substitutions of A to G and C to T 
in BLV-miRNA-B1-3p, G to A in BLV-miRNA-B2-3p, A 
to T in BLV-miRNA-B4-3p, and T to C in BLV-miRNA-
B5-5p were detected only in BLV genotype-6 strains.
BLV genotype‑9 specific mutations
Sixteen distinct novel BLV complete provirus genome 
sequences from Peru, Paraguay, and Bolivia were aligned 
with eight previously reported BLV whole genome 
sequences, including FLK-BLV pBLV913 [47], strains 
LS1-LS3 from Uruguay [48], strains Arg41and Arg38 
from Argentina [59, 60], and two strains from Japan 
[4] and the USA. As summarized in Fig. 11, ten unique 
amino acid substitutions were observed in genotype-9 
BLV strains as follows: (1) Two substitutions, E166D 
and D447G, in the Pol (RT) region; two substitutions, 
H644Y and A826T, in Pol (IN) region; and one substitu-
tion at residue 792 of the Pol (IN) region, restricted to 
only sequences of all 12 samples collected from Porta-
chuelo, but not in other genotype-9 strains. (2) In the 
Env (gp51) protein, one significant substitution, A133 V, 
was observed in all BLV genotype-9 strains and not 
(See figure on next page.) 
Fig. 9 Alignment of amino acid sequences of the BLV regulatory and accessory proteins. Alignment of amino acid residues corresponding to the 
regulatory proteins Tax (a) and Rex (b), and the accessory proteins R3 (c) and G4 (d) from a total of 16 South American BLV strains including one 
sample from Peru, seven from Paraguay and eight from Bolivia, together with that of the FLK‑BLV strain pBLV913. Identity with the FLK‑BLV strain is 
indicated by dots. a A putative zinc finger, leucine‑rich activation, and multiple functional domains in the Tax protein are shown in purple, blue, and 
pink, respectively. Sites of phosphorylation in the Tax protein are indicated in bold, italics, and underlined. b The nuclear export signal (NES) and the 
nuclear localization signal (NLS) in the Rex protein are shown in light purple and light red, respectively. d The leader peptide, the myb‑like motif (MYB), 
and the arginine‑rich nucleus targeting RNA‑binding region (ARR) are shown in orange, blue, and green, respectively. Two putative cellular protease 
cleavage sites are in italics and bold. Termination codons are shown by an asterisk
Page 15 of 23Polat et al. Retrovirology  (2016) 13:4 
a
b
c
d
Page 16 of 23Polat et al. Retrovirology  (2016) 13:4 
detected in eight known whole BLV genome sequences. 
Interestingly, another substitution in the Env (gp51) 
protein, S82L, was detected only in all of the 12 Porta-
chuelo strain sequences of genotype-9, but not in other 
genotype-9 sequences. (3) In the regulatory proteins Tax 
and Rex, substitutions at residue 108 (F108L) of Tax and 
residue 113 (A113E) of Rex were detected only in geno-
type-9 strains, but not in other strains or the eight known 
BLV genome sequences. In addition, a substitution at res-
idue 100 (P100S) of the Tax protein was observed only in 
samples collected from Portachuelo. (4) Likewise, a sub-
stitution at residue 26 (N26H) in the R3 accessory protein 
Fig. 10 Alignment of nucleotide sequences of BLV miRNAs. Alignments of the nucleotide sequences of miRNAs encoded by BLV strains from 16 
distinctive South American samples, including one from Peru, seven from Paraguay, and 8 from Bolivia, together with eight reference sequences 
from GenBank. miRNA seed regions are shown in yellow
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was detected only in the sequences of all genotype-9 BLV 
strains, but not in other strains or known BLV genome 
sequences. These ten substitutions were first detected 
in the sequences of the new genotype-9 strains identi-
fied in this study and the impact of these substitutions on 
the function of the proteins will require further study. In 
addition, 15, 7, and 22 unique amino acid substitutions 
were observed in BLV strains of genotypes-1, -2, and -6, 
respectively (Fig. 11).
Discussion
We draw four major conclusions from the results of this 
study of BLV in South American cattle. First, we identi-
fied a novel BLV genotype, genotype-9, in samples from 
two Bolivian provinces, Montero and Portachuelo, by 
phylogenetic analyses of partial env gp51 and whole 
genome sequences. Recent phylogenetic studies using 
BLV env gene sequences from strains isolated worldwide 
have classified the virus into eight genotypes [20–33]. 
Thus, the detection of genotype-9 is a novel finding of this 
study. Second, ML phylogenetic analysis of BLV whole 
genome sequences showed that genotype-9 sequences 
derived from Portachuelo were distinct from those col-
lected in Montero. Importantly, this result was obtained 
from BLV whole genome sequence data, but was not 
apparent from analyses of partial env gp51 sequences. 
Third, current research provides the new information 
of the full genome sequences of a novel genotype-9 and 
genotype-6 (partially known env sequences). Fourth, our 
data provides updated information about the spread of 
BLV infection in South American countries and demon-
strates a high rate of BLV infection in five countries: Peru, 
Paraguay, Bolivia, Argentina, and Chile. This informa-
tion will be important for the control of BLV infection in 
South America, and the data regarding the prevalence of 
BLV in Bolivia and Paraguay is unique to this study.
The most interesting data in this study are the phylo-
genetic results of the existence of genotype-9 confirmed 
Fig. 11 Summary of amino acid substitutions in sixteen novel and eight known BLV whole genome sequences. Amino acid substitutions identi‑
fied in at least three samples are shown. South American BLV strains from this study are marked according to the country of isolation as follows: 
Peru (filled triangle), Paraguay (filled circle), and Bolivia (filled diamond). Genotypes are indicated by numbers in the figure. Light red color indicates 
genotype‑9‑specific mutations detected in all samples, and light blue color indicates genotype‑9‑specific mutations detected only samples col‑
lected from Portachuelo in Bolivia
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by the ML method using 25 novel and eight previously 
reported BLV whole genome sequences (Fig.  4), which 
was in agreement with the phylogenetic analyses of 109 
partial env gp51 sequences obtained by two independent 
methods (Figs. 2, 3). Notably, the bootstrap value of the 
genotype-9 cluster was remarkably increased in the ML 
phylogenetic tree constructed from complete genome 
sequences (bootstrap value =  100  %), compared to that 
constructed using partial env sequences (bootstrap 
value  =  92  %). Therefore, the NGS analysis provided 
strong confirmatory evidence that genotype-9 is separate 
from the other eight genotypes.
As shown in Fig.  11, our comparison of BLV amino 
acid sequences showed that 10 unique amino acid sub-
stitutions were observed in the Pol, Env, Tax, Rex, and 
R3 regions of genotype-9 BLV strains. Importantly, two 
of these substitutions, including N792L in the Pol region 
and P100S in Tax, were observed only in samples col-
lected from Portachuelo assigned to genotype-9, indi-
cating the presence of at least two distinct genotype-9 
strains in Bolivia. This comparison also revealed that 15, 
7, and 22 unique amino acid substitutions are encoded by 
BLV genotypes-1, -2, and -6, respectively. This result was 
confirmed by ML phylogenetic analysis with BLV whole 
genome sequences, which also divided Bolivian geno-
type-9 sequences into at least two strains.
Phylogenetic analyses of the env gp51 gene also sug-
gested the possibility that genotype-6 may be divided 
into three sub-genotypes, including clades for (1) the 
FJ808582/Argentina strain, (2) the DQ059415/Brazil and 
AY185360/Brazil strains, and (3) our newly-identified 
sequences, including Paraguay-91. By whole genome 
analysis, Paraguay-62, which was assigned to clade (2) 
in the gp51 env analysis, was clearly divided from Para-
guay-91, with a bootstrap value of 100  %. Our previous 
work has also suggested that genotype-6 may be divided 
into three subgroups: G-6a, G-6b and G-6c [30]. There-
fore, these two branches, including Paraguay-62, and 
Paraguay-89 and -91 may be designated as separate geno-
types when additional whole genome sequences of geno-
type-6 are accumulated and analyzed in future.
This study revealed a widespread distribution and 
remarkably high levels of BLV in five South American 
countries, including Peru, Chile, Argentina, Paraguay, 
and Bolivia. In Peru, 139 of 328 cattle samples were posi-
tive for BLV provirus, with a prevalence rate of up to 
58.6 %. Of Peruvian samples, 58.6 % of those from Hol-
stein cattle in Lima were BLV positive, whereas 40.0 % of 
samples from Pucallpa gave positive results. Our results 
were consistent with those of Ch [44], who demonstrated 
that BLV infection is widespread in Peru; however, the 
percentages of BLV positive samples found in the Peru-
vian areas of Lima and Pucallpa were higher in our study 
than those reported by Ch (up to 31.0 %) [44]. In Argen-
tina, we found that 325 of 420 samples were BLV posi-
tive, with an overall prevalence of 77.4  % at individual 
level and up to 90.9 % at the herd level. These results are 
consistent with previous reports demonstrating that BLV 
is widespread in Argentina [26, 31, 41, 42, 61]. Argen-
tine samples were collected from farms in Buenos Aires, 
where a high individual BLV prevalence was reported by 
Trono et  al. [43] and our results were broadly consist-
ent with those of Trono et  al.; however, we detected a 
higher BLV prevalence at the herd level, since Trono et al. 
reported infection levels of 84 % [43]. In addition, at the 
individual level, the percentage (77.4 %) of BLV positive 
Argentine samples in our study was slightly higher than 
that reported by Monti et al. (70 %) [26], indicating a pos-
sible increased prevalence of BLV in Argentina. Com-
pared to Peru and Argentine, relatively few BLV positive 
samples were identified from Chile. However, from the 
distribution of BLV presented in Table 1, we can see that 
more breeds and a wider geographical area were involved 
in BLV infection in Chile, indicating a tendency towards 
widespread infection, in agreement with a previous study 
of BLV prevalence in this country [24]. By contrast, over 
50  % (76/139) of screened samples from Paraguay were 
BLV positive and all infected breeds in Paraguay demon-
strated a high level of BLV prevalence, ranging from 28.6 
to 71.4  % in the Holstein breed, with 36.4  % in Brown 
Swiss cattle. In Bolivia, 156 of 507 samples were BLV 
positive and the BLV infection level differed from farm to 
farm. There are no previous data detailing the prevalence 
of BLV in Paraguay and Bolivia, and our result is the first 
report confirming the presence of BLV in these countries.
Based on sequencing results from the BLV provirus, 
the predicted amino acid sequences of the partial and full 
gp51 env gene from Peruvian, Paraguayan, and Bolivian 
BLV strains were highly conserved. Amino acid substi-
tutions in the gp51 protein were mostly located in the 
second neutralization domain, which is consistent with 
previous studies [32, 33]. In this study, only two distinct 
genotype-1 BLV strains from Paraguay had amino acid 
changes at positions 134 (D134N) and 146 (F146S) of 
the second neutralizing domain. These two substitutions 
were also observed in Brazilian and Uruguayan BLV gen-
otype-1 strain isolates [33], indicating that these amino 
acid substitutions exist mainly in South American BLV 
strains, and suggesting a common origin for these virus 
strains. Interestingly, Moratorio et al. [33] confirmed that 
D134N changes the net charge of a loop of the Env pro-
tein, indicating a potential impact of this substitution on 
virus-host interactions. BLV strains grouped into geno-
type-2 showed a common substitution, N141D. Interest-
ingly, the V191I substitution in the B epitope, observed 
in only one distinct BLV strain from Peru in this study, 
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has been reported in some Argentine BLV isolates [33]. 
Most importantly and interestingly, an A133V substitu-
tion in the second neutralization domain was observed in 
only genotype-9 BLV strains. Previous data have demon-
strated amino acid changes of alanine to aspartic acid (A 
to D) or threonine (A to T) [32] at this residue, but there 
are no previous reports of alanine to valine substitutions, 
indicating that A133V is a novel finding of this study.
At present, there are eight full-length BLV genome 
sequences available in the GenBank database. The major 
limitations of Sanger sequencing compared to Next Gen-
eration methods are increased time and cost, and the 
limited amount of data generated by sequencing runs. 
The rapid development of NGS (DNA and RNA-seq) 
has accelerated sequencing analysis of new genomes and 
transcriptomes of complex organisms, allowing the iden-
tification of new virus species integrated within complete 
or draft genome sequences. Commonly, virus genomes 
are very compact and the sequences have multiple func-
tions, such as protein encoding (sometimes for multiple 
proteins), transcription, regulation of host genes, and 
virus genome packaging. Therefore, identification of 
complete viral genome sequences is becoming increas-
ingly important. In this study, we identified both BLV 
partial env and complete viral genome sequences from 
the same samples. Our data indicate that the BLV env 
sequence is a good target for classification of BLV strains, 
and analysis of env sequences was helpful for selection of 
informative strains to include in the complete genome 
sequence analysis.
In this study, we sequenced complete genomes of 25 
BLV strains, including 17 novel genotype-9 strains. Our 
results revealed that BLV genomes contain a number of 
unique genotype specific substitutions not only in the 
env region, but also in the LTR, Gag, Pro, Pol, Tax, Rex, 
R3, G4, and miRNA encoding regions. The Informa-
tion about substitutions in viral genomes is important 
for investigating viral spread worldwide. Therefore, full 
understanding of the biological functions of these geno-
type specific substitutions is now essential. By contrast, 
we also found that BLV genome sequences of strains 
from different geographic origins, especially the impor-
tant sites on the regulation of viral replication of BLV, are 
relatively stable and highly conserved as follows. Three 
copies of CRE sequences were imperfectly conserved in 
all strains of each genotype. Merezaki et al. (2001) found 
that introducing a perfect CRE sequences into TxRE 
increases the BLV LTR promoter activity, suggesting that 
imperfect conservation of CREs repress viral expression 
with escape from the host immune response [62]. Fur-
thermore, deep sequencing results of the current study 
were consistent with previous result [28] that all of the 
eight N-linked glycosylation sites are conserved very well. 
The absence of mutation of N-linked glycosylation sites 
in naturally infected cattle is explained by the hypothesis 
as being favorable for the virus to coexist with its host 
for efficient replication and transmission [63]. Moreover, 
the two phosphorylation sites on Tax protein, and NES 
and NLS regions in Rex protein were also conserved well. 
Thus, the fact that limited sequence variations are com-
patible with the development of a vaccine [19, 64, 65].
Conclusion
The present study provides the first evidence of the prev-
alence of BLV infection among cattle in Paraguay, Peru, 
and Bolivia, and also confirms the widespread distribu-
tion of BLV infection in Argentina and Chile. Our BLV 
genotyping studies demonstrate that Peruvian and Para-
guayan BLV strains are of genotypes-1, -2, and -6. Of 
interest, our findings indicate that Bolivian BLV strains 
are clustered into genotypes-1, -2, -6, and -9. The exist-
ence of the novel genotype-9 was confirmed by compre-
hensive phylogenetic analyses of both partial gp51 env 
and full BLV genome sequences.
Methods
Experimental samples and extraction of proviral DNA
Blood samples were obtained from a total of 2204 cat-
tle, including 328 from three different farms in Peru, 
139 from five farms in Paraguay, 507 from eight farms 
in Bolivia, 420 from three farms in Argentina, and 810 
from 19 farms in Chile (Fig.  1; Table  1). Farms located 
in main-cattle raising area were chosen for sampling in 
each country. All animals were handled by veterinarians 
from RIKEN, Universidad Austral de Chile and LAVET, 
in strict accordance with good animal practice following 
the Universidad Austral de Chile Institutional guidelines. 
This study was approved by the Committee on the Eth-
ics of Animals for Research at the National University of 
LA PLATA (Certificate date May 26th, 2014) and by the 
Committee on the Ethics of Animals for Research at Uni-
versidad Austral de Chile (Certificate No. 153-2014).
Proviral DNA was extracted from 40 μl of whole blood 
spotted onto Whatman FTA elute cards (GE Healthcare 
Japan Corp., Tokyo, Japan), according to the manufac-
turer’s instructions. The extracted DNA was stored at 
−20  °C until required for PCR. Cattle were classified as 
BLV-infected where genomic integration of the BLV pro-
virus was detected.
Detection of BLV provirus by nested PCR
Each sample was screened for the presence of BLV pro-
virus by the detection of BLV LTR regions using nested 
PCR, as described previously [30, 66]. Briefly, the 
first PCR amplification was performed with primers 
BLTR256F (5′-GAGCTCTCTTGCTCCCGAGAC-3′) 
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and BLTR453R (5′-GAAACAAACGCGGGTGCAAGC 
CAG-3′). As an internal control, the BoLA-DRA gene was 
amplified using primers BDRA488F (5′-ACAACACC 
CCAAACACCAAT-3′) and BDRA1145R (5′-AGGAA 
GGGGAGGTAGTGGAA-3′). Five picomoles of each 
primer, 2  μl of 10× rTaq PCR Buffer (Toyobo, Osaka, 
Japan), 2 μl of 25 mM MgCl2, 2 μl of 2 mM dNTP mix, 
0.1  μl of 5U/μl rTaq, and 10.4  μl of nuclease-free water 
were added to each sample, which was amplified in a final 
volume of 20 μl for 45 cycles of 94 °C for 30 s, 58 °C for 
30 s, and 72  °C for 30 s, and then a final extension step 
of 4  min. Two μl of Exo-SAP IT (USB Corp., Cleve-
land, OH, USA) was applied to the initial PCR prod-
ucts and incubated at 37 °C for 15 min, then at 80 °C for 
15  min. The initial PCR amplicons were subsequently 
applied to the second PCR with primers BLTR306F 
(5′-GTAAGGCAAACCACGGTTT-3′) and BLTR408R 
(5′-AGGAGGCAAAGGAGAGAGT-3′). Five picomoles 
of each primer, 2  μl of 10× rTaq PCR Buffer, 2  μl of 
25  mM MgCl2, 2  μl of 2  mM dNTP mix, 0.1  μl of 5U/
μl rTaq, and 11.9 μl of nuclease-free water were added to 
1  μl of each purified PCR product. Sterilized water was 
used as a PCR negative control.
PCR amplification and sequencing of BLV env gene 
fragments
One hundred and thirty-one BLV field strain samples, 
consisting of 41, 34, and 56 from Peru, Paraguay, and 
Bolivia, respectively, representing 30  % of BLV positive 
samples collected from each country, were randomly 
chosen for amplification of the BLV env gene. The par-
tial BLV env gene was amplified by nested PCR. PCR 
amplification was performed using PrimeSTAR GXL 
DNA Polymerase (Takara Bio Inc., Otsu, Japan) and the 
following primers: external forward (5′-ATGCCYAAA 
GAACGACGG-3′) and external reverse (5′-CGACGG 
GACTAGGTCTGACCC-3′) described previously [33], 
and Env5032 (5′-TCTGTGCCAAGTCTCCCAGATA-3′) 
and Env5608r (5′-AACAACAACCTCTGGGAAGGGT-3′) 
for second-round PCR [67]. The reaction mixture con-
tained 13.5 μl (initial PCR) and 14.5 μl (second PCR) of 
distilled water, 5 μl of 5× PS GXL Buffer, 2 μl of 2.5 mM 
dNTP mix, 0.5 μl of PrimeSTAR GXL, and 1 μl of each 
primer (10 μM). Conditions for PCR amplification were 
as follows: 98 °C for 2 min, followed by 30 cycles of dena-
turation at 98 °C for 15 s, annealing at 60 °C for 20 s, and 
extension at 68 °C for 60 s. The external primers resulted 
in amplification of a 913 bp DNA fragment, and internal 
primers amplified a 597 bp fragment of the gp51 region 
of the env gene.
Positive second-round PCR products were purified 
using Exo-SAP IT (USB Corp., Cleveland, OH, USA) and 
sequenced on an ABI3730xl DNA Analyzer using an ABI 
PRISM Big Dye Terminator v 3.1 Ready Reaction Cycle 
Sequencing Kit (Applied Biosystems, Foster City, CA, 
USA). Sequences included a 475 bp sequence of the env 
gene, corresponding to nucleotide positions 5090–5564 
of the BLV cell line FLK-BLV subclone pBLV913 com-
plete genome (GenBank accession number EF600696) 
[47]. Editing, alignment, and identification of nucleotide 
sequences were performed using MEGA 5.1 software 
[68].
Phylogenetic analysis of env nucleotide sequences
The 131 BLV env partial sequences from Peru, Para-
guay, and Bolivia were successfully amplified. Because 
of strains showing homology to each other, 35 distinc-
tive sequences among the 131 were aligned with 74 BLV 
env sequences from GenBank, including sequences from 
other South American countries and also of BLV isolates 
from other parts of the world, representative of the eight 
known BLV genotypes, using MEGA 5.1 software [68]. 
For robust and accurate phylogenetic analysis of the BLV 
env gp51 partial sequences, phylogenetic trees were con-
structed using two different algorithms.
First, ML trees were constructed using MEGA 5.1 [68] 
and Kimura 2-parameter model plus gamma distribution 
(K2+G) was chosen as the best model for nucleotide sub-
stitution [69]. For the ML analysis, the reliability of the 
phylogenetic relationships was evaluated using nonpara-
metric bootstrap analysis with 1000 replicates.
Next, to confirm the data obtained by ML analysis, BI 
was performed using MrBayes v.3.2.5 [70] with the evo-
lutionary model set to lset nst =  6, rates =  equal [cor-
responding to the general-time-reversible model (GTL)]. 
In BI analysis, two runs with four Markov chains were 
carried out simultaneously for 100,000,000 generations, 
and the trees were sampled every 100 generations. The 
first 25 % of the BI trees were discarded as “burn-in”. A 
consensus tree was constructed from the output file pro-
duced in the BI analysis using FigTree v. 1.4.2 (http://tree.
bio.ed.ac.uk/software/figtree/).
PCR amplification of the whole BLV provirus
To gain insight into the genetic differences between the 
distinct BLV genotypes, PCR amplification of overlap-
ping genomic fragments (Additional file  1: Figure S1) 
covering the complete BLV genome of 25 South Ameri-
can samples was achieved using the PrimeSTAR GXL 
DNA Polymerase (Takara Bio Inc., Otsu, Japan) and spe-
cific primers designed for this study (Life Technologies 
Japan Ltd, Tokyo, Japan) (Additional file  1: Figure S1). 
The 25  μl final reaction mixture contained 5  μl of 
5× PrimerSTAR GXL Buffer, 2  μl of 2.5  mM dNTP 
mix, 1 μl of each primer at a concentration of 10 pmol, 
3  μl of template and 0.5  μl of PrimerSTAR GXL DNA 
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Polymerase. The cycles for the PCR amplification were as 
follows: 98 °C for 2 min, followed by 33 cycles of denatur-
ation at 98 °C for 15 s, annealing at 60 °C for 20–30 s, and 
extension at 68 °C for 1–6 min (1 min per kilobase), fol-
lowed by a final extension at 72 °C for 4 min. Each ampli-
con was quantified using the Qubit dsDNA BR Assay kit 
(Life Technologies Ltd, Oregon, OR, USA) and four dif-
ferent BLV provirus genome PCR amplicons from each 
individual were pooled together at an equimolar ratio to 
a final concentration of 30 ng/μl as the starting material 
for whole genome sequencing library preparation.
BLV whole genome library preparation
DNA libraries of the above-mentioned pooled samples 
were prepared by a transposase-mediated library prepa-
ration method, using the SureSelect QXT Library prep 
for Illumina Multiplexed Sequencing Kit (Agilent Tech-
nologies, Santa Clara, CA, USA). Briefly, 30  ng of each 
pooled sample was treated with 1  μl of the SureSelect 
QXT enzyme mix ILM and 8.5  μl of QXT buffer, and 
incubated for 10  min at 45  °C, followed by addition of 
16 μl of QXT stop solution, enabling enzymatic fragmen-
tation and addition of adaptors to the ends of fragments 
in a single reaction. The adaptor-tagged library fragments 
were purified using Agencourt AMPure XP beads (Beck-
man Coulter, Inc., Brea, CA, USA) with the NGS Magna 
Stand Ch YS-Model (NIPPON Genetics Co., Ltd., Tokyo, 
Japan) according to the manual. Next, each purified adap-
tor-tagged library was PCR amplified with 1  μl of each 
of the indexing primers, P5 and P7, added to the index 
in a reaction mixture containing 5 μl of 5× Herculase II 
reaction buffer, 0.25 μl of 100 mM dNTP mix, 1.25 μl of 
dimethyl sulfoxide (DMSO), 0.5 μl of Herculase II Fusion 
DNA Polymerase, and 6  μl of water to a final volume 
of 25  μl. Each sample was dual indexed. The amplified 
libraries were purified with AMPure XP beads (Beck-
man Coulter Inc., Brea, CA, USA). The quality and quan-
tity of amplified libraries were assessed using the Agilent 
2100 Bioanalyzer (Agilent Technologies, Waldbronn, 
Germany) and DNA 1000 Assay. The final dual indexed 
libraries were pooled into one at equimolar concentra-
tions. The library was subjected to multiplex sequencing 
on the MiSeq sequencer (Illumina).
NGS sequence data analysis
Sequence data analysis followed a framework described 
previously [71]. Briefly, Fastq files were generated as row 
sequences by the Illumina MiSeq, with 600 cycles of 
paired-end read, and validated by evaluation of the dis-
tribution of quality scores. Validated fastq files from each 
viral genome were aligned with the Burrows-Wheeler 
Aligner tool (BWA v. 0.7.8-r455) [72] against a refer-
ence sequence and the resulting Alignment Map (SAM) 
format output was suitable for analyses using SAMTools 
[73]. Analysis of sequence quality, depth of coverage, 
short-read alignment, and variant identification were 
performed using SAMTools [73]. The indexed file was 
visualized using the Integrative Genomics Viewer (IGV) 
[74]. The BLV cell line FLK-BLV subclone pBLV913 
(GenBank accession number: EF600696) [47], BLV strain 
Arg41 (GenBank accession number: FJ914764) [59], and 
BLV (GenBank accession number: AF033818) complete 
genomes were used as reference sequences. Full genome 
consensus sequences of each individual BLV strain were 
saved for further analyses, including alignment using 
MAFFT v7.123b (http://mafft.cbrc.jp/alignment/soft-
ware/) and deduction of protein sequences by in silico 
translation of nucleotide to amino acid sequences using 
MEGA 5.1 [68].
BLV genome sequences (8728  bp) were aligned using 
MAFFT software, and the nucleotide and amino acid 
substitution per site was calculated using the Jukes and 
Cantor [75], and p-distance models [68], respectively. A 
ML tree for full BLV genome sequences was constructed 
using MEGA 6.06 software [76], and 1000 replications 
were used to calculate bootstrap values.
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